Showing results (141-150 of 161) with videos related to

Sort By:
Pageof 17
Mayo Clinic Proceedings|August 11, 2023
Obesity, Cardiorenal Comorbidities, and Risk of Hospitalization in Patients With Heart Failure With Preserved Ejection FractionCamilla S Morgen, Christiane L Haase, Tugce K Oral, et al.
Drug Metabolism and Disposition: the Biological Fate of Chemicals|December 28, 1999
Disposition and metabolism of cetrorelix, a potent luteinizing hormone-releasing hormone antagonist, in rats and dogsM Schwahn, H Schupke, A Gasparic, et al.
The Journal of Clinical Endocrinology and Metabolism|November 18, 2011
LCAT, HDL cholesterol and ischemic cardiovascular disease: a Mendelian randomization study of HDL cholesterol in 54,500 individualsChristiane L Haase, Anne Tybjærg-Hansen, Abbas Ali Qayyum, et al.
Chaos (Woodbury, N.Y.)|June 5, 2003
Stochastic resonance in coupled nonlinear dynamic elementsM. Locher, D. Cigna, E. R. Hunt, et al.
Obesity Science & Practice|April 12, 2021
Body mass index trajectories among people with obesity and association with mortality: Evidence from a large Israeli databaseOrna Reges, Dror Dicker, Christiane L Haase, et al.
Circulation. Cardiovascular Genetics|August 12, 2011
Heterozygosity for R1141X in ABCC6 and risk of ischemic vascular diseaseLouise S Hornstrup, Anne Tybjærg-Hansen, Christiane L Haase, et al.
International Journal of Epidemiology|November 2, 2014
Subgroups at high risk for ischaemic heart disease:identification and validation in 67 000 individuals from the general populationRuth Frikke-Schmidt, Anne Tybjærg-Hansen, Greg Dyson, et al.
Geburtshilfe Und Frauenheilkunde|April 29, 2014
Pregnancy and Birth After a Two-Step PGD: Polar Body Diagnosis for Hemophilia A and Array CGH on Trophectoderm Cells for Chromosomal AberrationsW Würfel, R Suttner, D Shakeshaft, et al.
Chirality|January 1, 1997
Enantioselective high-performance liquid chromatography assay of (+)R- and (-)S-alpha-lipoic acid in human plasmaG Niebch, B Büchele, J Blome, et al.
Obesity Science & Practice|September 3, 2020
Real-world persistence with liraglutide 3.0 mg for weight management and the SaxendaCare® patient support programSean Wharton, Christiane L Haase, Elham Kamran, et al.
Pageof 17